CORRECTION OF THE NON-ALCOHOLIC STEATOHEPATITIS MANIFESTATIONS IN THE PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY

The article proves the effectiveness of the ursodeoxycholic acid drug application for the non-alcoholic steatohepatitis treatment in the patients with hypertension and obesity. Application of the ursodeoxycholic acid drug accelerates normalization of clinical manifestations, normalization of biochemical parameters of liver function and lipid metabolism, reduces sonographic phenomenon of the fatty liver infiltration. The positive clinical effects and positive dynamics of biochemical and sonographic indicators confirm enhancement of metabolism in the liver cells in the majority of patients. These factors may recommend the ursodeoxycholic acid application for treatment and prevention.